- Home
- RVPH vs WLGS Comparison
RVPH vs WLGS Comparison
Compare RVPH & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- WLGS
- Stock Information
- Founded
- RVPH 2006
- WLGS 1981
- Country
- RVPH United States
- WLGS Hong Kong
- Employees
- RVPH N/A
- WLGS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- WLGS Engineering & Construction
- Sector
- RVPH Health Care
- WLGS Consumer Discretionary
- Exchange
- RVPH Nasdaq
- WLGS Nasdaq
- Market Cap
- RVPH 50.0M
- WLGS 41.7M
- IPO Year
- RVPH N/A
- WLGS 2023
- Fundamental
- Price
- RVPH $1.78
- WLGS $1.97
- Analyst Decision
- RVPH Strong Buy
- WLGS
- Analyst Count
- RVPH 4
- WLGS 0
- Target Price
- RVPH $15.33
- WLGS N/A
- AVG Volume (30 Days)
- RVPH 5.1M
- WLGS 167.4K
- Earning Date
- RVPH 11-14-2024
- WLGS 12-31-2024
- Dividend Yield
- RVPH N/A
- WLGS N/A
- EPS Growth
- RVPH N/A
- WLGS N/A
- EPS
- RVPH N/A
- WLGS N/A
- Revenue
- RVPH N/A
- WLGS $6,825,879.00
- Revenue This Year
- RVPH N/A
- WLGS N/A
- Revenue Next Year
- RVPH N/A
- WLGS N/A
- P/E Ratio
- RVPH N/A
- WLGS N/A
- Revenue Growth
- RVPH N/A
- WLGS 63.69
- 52 Week Low
- RVPH $0.60
- WLGS $0.44
- 52 Week High
- RVPH $5.67
- WLGS $5.57
- Technical
- Relative Strength Index (RSI)
- RVPH 53.02
- WLGS 38.28
- Support Level
- RVPH $1.23
- WLGS $1.06
- Resistance Level
- RVPH $1.75
- WLGS $2.50
- Average True Range (ATR)
- RVPH 0.53
- WLGS 0.60
- MACD
- RVPH -0.07
- WLGS -0.18
- Stochastic Oscillator
- RVPH 18.57
- WLGS 29.50
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.